MOTS-c vs GHK-Cu vs BPC-157: Three Research Peptides Compared

These three compounds sit in almost every research-peptide catalogue, but they have nothing structurally in common — one is mitochondrial-derived, one is a copper-binding tripeptide, and one is a synthetic pentadecapeptide. This is a factual comparison for a research audience: where each comes from, how they differ structurally, and what the published literature studies them for. It is not medical guidance and not a recommendation for any use in humans.

Where each comes from

MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is unusual among peptides because it is encoded in the mitochondrial genome rather than the nuclear one — part of a class called mitochondrial-derived peptides, first described in 2015. It is 16 amino acids long, and the research literature studies it in the context of cellular metabolism and metabolic signalling pathways.

GHK-Cu is the smallest of the three by far: a naturally occurring tripeptide (glycyl-histidyl-lysine) complexed with a copper(II) ion. It was first isolated from human plasma in the 1970s, and the literature around it centres on copper transport and its activity in in-vitro skin and tissue models.

BPC-157 is a synthetic pentadecapeptide — 15 amino acids — derived from a partial sequence of a protein found in gastric juice. Unlike the other two it does not occur naturally in that form. The published research on it is largely preclinical, in cell and animal models.

Side-by-side

Molecular weights are nominal reference figures; always use the value on the specific lot's Certificate of Analysis for solution calculations.

What the structural differences mean at the bench

The practical differences for a researcher are mostly about handling and quantification. GHK-Cu's tiny size and copper centre give it distinct chemistry — the copper complex is coloured (solutions run blue-violet), and its molarity per milligram is roughly six times that of MOTS-c because the molecule is so much smaller. MOTS-c and BPC-157 are conventional lyophilised peptides: white powder, reconstituted with standard technique, stored at −20°C desiccated. For all three, the identity question is the same — a vial's label is a claim, and only lot-specific mass-spec identity and HPLC purity testing turn that claim into data.

The common denominator: verify before you buy

Whichever of the three a study calls for, the supply-side risk is identical: substitution and under-purity are the classic failure modes of this market, and neither is visible by eye. A batch-specific Certificate of Analysis — identity by mass spectrometry, purity by HPLC, tied to the lot code on your vial and checkable before you order — is the one control a researcher has over what actually arrives. At DNR, every lot ships with exactly that, and batch codes are verifiable on our site.

In short

MOTS-c, GHK-Cu and BPC-157 are three structurally unrelated tools studied in three different corners of the literature — metabolic signalling, copper biology, and preclinical models respectively. Choose by the receptor, pathway or model your research needs, and whichever you choose, let the Certificate of Analysis — not the label — tell you what's in the vial.

Browse the DNR research catalogue →

For laboratory and research use only. Not for human or veterinary consumption. This page summarises publicly published research context only and makes no claim of any effect in humans.